Advisory Services Network’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Advisory Services Network’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2	Closed	–	–	3418
2019 Q3	$0	Hold	2	–	–	﹤0.01%	2888
2019 Q2	$0	Hold	2	–	–	﹤0.01%	3000
2019 Q1	$0	Hold	2	–	–	﹤0.01%	2824
2018 Q4	$0	Hold	2	–	–	﹤0.01%	2791
2018 Q3	$0	Hold	2	–	–	﹤0.01%	2713
2018 Q2	$0	Hold	2	–	–	﹤0.01%	2830
2018 Q1	$0	Hold	2	–	–	﹤0.01%	2811
2017 Q4	$0	Hold	2	–	–	﹤0.01%	2705
2017 Q3	$0	Hold	2	–	–	﹤0.01%	2519
2017 Q2	$0	Hold	2	–	–	﹤0.01%	2456
2017 Q1	$0	Buy	+2	New	+$9	﹤0.01%	2256
2016 Q3	$0	Hold	2	–	–	﹤0.01%	2160
2016 Q2	$0	Hold	2	–	–	﹤0.01%	2045
2016 Q1	$0	Hold	2	–	–	﹤0.01%	1882
2015 Q4	$0	Hold	2	–	–	﹤0.01%	1713
2015 Q3	$0	Hold	2	–	–	﹤0.01%	1682
2015 Q2	$0	Hold	2	–	–	﹤0.01%	1582
2015 Q1	$0	Hold	2	–	–	﹤0.01%	1397
2014 Q4	$0	Buy	+2	New	+$46	﹤0.01%	1265
2014 Q1	–	Sell	-2	Closed	–	–	1047
2013 Q4	$0	Buy	+2	New	+$36	﹤0.01%	1104

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advisory Services Network's CTIC Position: Q4 2019 in Review

Advisory Services Network sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2019, closing a stake of 2 shares.

Advisory Services Network first reported a position in CTIC in Q4 2013 and held it in 20 quarters. The position peaked at $0 in Q3 2019. 40 funds tracked by Wall St. Rank hold CTIC as of Q4 2019.

Advisory Services Network reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2019 after selling out during the quarter.
Advisory Services Network sold 2 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2019.
Advisory Services Network first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and held it in 20 quarters.
Advisory Services Network's CTI BioPharma Corp. (DE) Common Stock position peaked at $0 in Q3 2019.
40 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2019.

Based on Advisory Services Network's 13F filing for Q4 2019, filed 4 Feb 2020.